Rich Horgan believes that there’s an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases.

The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner.

Transformations in the Life Sciences is the focus of the second season of the MedCity Pivot Podcast. My personal journey as a caregiver of a cancer patient made me choose Dr. Sumanta Pal, co-director of the City of Hope’s Liver Cancer program as a guest after he co-authored an interesting study on immunotherapy that was published in the Lancet.

I interview Punit Singh Soni, CEO of Suki and Niall O’Connor, CTO, Cohere Health to evaluate two areas where AI can have an outsize impact: clinical documentation and prior authorization.

A conversation with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab about responsible AI.

Season 2 of our MedCity Pivot Podcast launches today with a conversation about how AI can be leveraged to transform precision medicine.

Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company’s Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid.

Steve Driver is an interventional cardiologist as well as medical director of digital therapeutics at Advocate Aurora Health, which last year merged with Atrium Health. In this episode, he talked about a pilot involving Omada Health targeting a prediabetes population, among other things.

Season one focusing on chronic disease management kicks off with a conversation with Stephanie Tilenius, CEO of Vida Health that aims to treat both the mind and the body.

Kharraz made a bold declaration about telehealth back in December 2020. In the final episode of 2022, we ask him about that and more.

Miruna Sasu, CEO of RWE company COTA, explained that studies have shown meaningful improvements in efficiency if RWE is used in drug development and that translates into real savings. However, will such efforts continue amidst the ongoing belt-tightening in a tough economy?

In this episode, we are conversing with Sonia Millsom, CEO of executive search firm Oxeon, to discuss trends shaping the marketplace following the Great Resignation as well as how Oxeon is spurring innovation through its venture studio.

Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusi talked about the pharma company’s work in HIV and hepatitis and how her personal background informed her team’s work in developing a Covid-19 treatment.

Digital health technologies have received plenty of attention, cash and sky-high valuations but do they deserve it? In the latest episode of MedCity’s Pivot podcast, CEO of Hinge Health says companies need to validate their results in order to move the industry forward.

Renee Ryan hopes to see the vision of Cala Health’s founder – who believed that Cala Health’s wearable neurostimulation device can be one of the treatment modalities for chronic diseases like essential tremor – translated to reality.

Hurdle wants to address mental healthcare for minority populations whose problems are not well-addressed by the prevalent healthcare infrastructures. Learn about cultural humility (not cultural competency) and how that can address the depression and anxiety felt by so many. My own recent loss helps me understand the important work that Kevin and others are undertaking.

The Covid-19 pandemic has propelled virtual healthcare into our daily lives, although the quality of that experience varies. But one emerging trend from the scaling of telehealth is virtual-first care, as Wheel CEO and founder Michelle Davey explained.

In a wide-ranging discussion, Amwell Chairman & CEO Ido Schoenberg expressed frustration at being lumped together with other telehealth companies that have very different approaches and business models. But he was also very optimistic about the category overall.

Mike Alkire talked about the importance of health systems achieving scale such that they are in a better position vis-a-vis payers who are typically much larger.

In our conversation, Adrienne McFadden, who at one time was a practicing physician, speaks about the evolution of the company to more of a curated matchmaker connecting and guiding people to the best care available. 

In this episode of the MedCity Pivot Podcast, Jonathan Bush talks about his latest venture – Zus Health – through which he wants to help digital health companies share data to create a universal patient off of which new products can be created to serve payers, providers and others with the ultimate goal of improving patient outcomes.

In this episode, I speak with John Martin, chief medical officer of Butterfly Network about how it is trying to transform the practice of medicine through a handheld ultrasound probe and data platform.

A conversation with Taha Kass-Hout reveals how machine learning can be leveraged to really harness data to improve outcomes and ultimately put people on a path to precision health.

Lark Health is betting on a texting platform that if 100 percent driven by conversational AI to help patients manage their chronic conditions better.

After more than a year’s worth of interviewing external experts, the Pivot podcast is turning its gaze inward to demystify — as much as possible — why we write the stories we write.

Sarah Boyce knows she is a rare breed – a female biotech CEO. In this episode, Boyce talks about the novel therapy she is trying to develop to tackle a rare genetic muscle condition, while also building a company that is committed to diversity and inclusion.

In this episode, Dr. Pearl who led the Permanente Medical Group for almost two decades and is the author of a new book on physician culture, reveals how doctors may be unintentionally harming the healthcare system and how that culture needs to be transformed for the betterment of all involved.

It’s important for clinicians to consider AI recommendations with a critical eye, the same as they would for any other test, said Dr. Erich Huang, Director of Duke Forge. In our latest podcast episode, he spells out the stakes for implementing algorithms in healthcare, which can potentially affect thousands of patients.

Livongo’s founder has created a new care navigation venture because he believes that both the experience that people undergo as they look for care and the level of risk that vendors are willing to take when they work with self-insured employers leave much to be desired.

Ho Sung Cho, senior vice president of Biodiscovery Therapeutics at Bristol Myers Squibb, talks about lessons learned from drug discovery, recent success tied to Covid-19, and how the company is leveraging its expertise in protein degradation to develop novel therapies for blood cancers, solid tumors and other important therapeutic areas.